18.05.2023 10:02:00

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EMAN, ARNC, AMED

NEW YORK, May 18, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC (PRNewsfoto/Halper Sadeh LLP)

eMagin Corporation (NYSE: EMAN)'s sale to Samsung Display Co., Ltd. for $2.08 per share in cash. If you are a eMagin shareholder, click here to learn more about your rights and options.

Arconic Corporation (NYSE: ARNC)'s sale to affiliates of Apollo Global Management, Inc. for $30.00 per share in cash. If you are an Arconic shareholder, click here to learn more about your rights and options.

Amedisys, Inc. (NASDAQ: AMED)'s sale to Option Care Health, Inc. for 3.0213 shares of Option Care common stock for each share of Amedisys common stock. If you are an Amedisys shareholder, click here to learn more about your rights and options.  

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060 
sadeh@halpersadeh.com 
zhalper@halpersadeh.com 
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-eman-arnc-amed-301828137.html

SOURCE Halper Sadeh LLP

Nachrichten zu eMagin Corpmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu eMagin Corpmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Amedisys Inc. 80,50 0,00% Amedisys Inc.